Table 1: Kind of patients we performed the Lavender Procedure on, from primary breast cancers to local recurrences and some larger tumors.

	Group I (11 patients)	Group II (4 patients)	Group III (6 patients)
Ages	43-86	65-75	38-81
Tumors	5mm-1.1cm	Tis (DCIS) - 8mm	Tis (prior lumpectomy) - 3.5cm
Breast	UOQ - 6, UIQ - 2, LIQ - 2, LOQ - 1	UOQ - 3, LIQ - 1	UOQ - 5, LOQ - 1
Markers	ER+ 8, PR+ 8, Her2- neg (7)	ER+ 4, PR+ 3, Her2+	ER+ 3,PR+ 1, Her2+1
Ki-67	mostly very low	N/A	no data
Nodes	all clinically and U/S benign	all clinically neg/ U/S benign	all palpable nodes
Freeze ball	4-5cm	3cm	5cm
Saline	7 yes, 4 no	2 yes, 2 no	all
Anti-estrogen	most all	most all	mostly refused
Sequence	usually 6-10-6	usually 6-10-6, one 4-10-4 (recurrence)	multiple attempts
Old Local Recurrence	2 (FROM IDC 2003 & 2007)	2 one DCIS and another second primary	1
Anaesthesia	0.25% Marcaine without epi uniformly
EBL	Minimal	Minimal	Minimal
Complications	0	0	0
Alive cancer-free	10	3	1
Deaths	1 from fall not breast cancer	1 from primary lung not breast	One died we can verify as some in Group III were from foreign countries where we lost contact.

The authors understand this is a small patient population and no real statistics can be rendered. However, how many times does one need to jump out of an airplane with and without a parachute to know that jumping out with a parachute is far superior and no multicenter clinical trial is needed to prove it. Having been trained in the radical surgery era, from our first case we knew this methodology was a real game changer. Every woman is not a statistic but a valued human life. Our endeavors are meant to show the way to others who will venture into cryoablation, aka The Lavender Way/Procedure. Find it early, kill it early. If you or your country need help, contact us.